XOMA Ltd. and Aragen Bioscience, Inc. have entered into an agreement under which Aragen Bioscience will provide its clients with access to XOMA’s Human Engineering technology for antibody humanization. Financial terms were not disclosed.   “Access to XOMA’s extensive technology and expertise in antibody humanization allows Aragen Bioscience to provide its customers a seamless transition from murine antibody discovery and sequencing to antibody testing, variable domain humanization, stable an...